Literature DB >> 30091004

Vagus nerve stimulation as a tool for enhancing extinction in exposure-based therapies.

Lindsey J Noble1, Rimenez R Souza1, Christa K McIntyre2.   

Abstract

RATIONALE: Emotionally traumatic experiences can lead to maladaptive memories that are enduring and intrusive. The goal of exposure-based therapies is to extinguish conditioned fears through repeated, unreinforced exposures to reminders of traumatic events. The extinction of conditioned fear depends upon the consolidation of new memories made during exposure to reminders. An impairment in extinction recall, observed in certain patient populations, can interfere with progress in exposure-based therapies, and the drive to avoid thoughts and reminders of the trauma can undermine compliance and increase dropout rate. Effective adjuncts to exposure-based therapies should improve the consolidation and maintenance of the extinction memory or improve the tolerability of the therapy. Under stressful conditions, the vagus nerve responds to elevations in epinephrine and signals the brain to facilitate the storage of new memories while, as part of the parasympathetic nervous system, it slows the sympathetic response.
OBJECTIVE: Here, we review studies relevant to fear extinction, describing the anatomical and functional characteristics of the vagus nerve and mechanisms of vagus nerve stimulation (VNS)-induced memory enhancement and plasticity.
RESULTS: We propose that stimulation of the left cervical vagus nerve during exposure to conditioned cues signals the brain to store new memories just as epinephrine or emotional arousal would do, but bypasses the peripheral sympathetic "fight-or-flight" response.
CONCLUSIONS: In support of this hypothesis, we have found that VNS accelerates extinction and prevents reinstatement of conditioned fear in rats. Finally, we propose future studies targeting the optimization of stimulation parameters and the search for biomarkers of VNS effectiveness that may improve exposure therapy outcomes.

Entities:  

Keywords:  Anxiety; Extinction; Fear; Posttraumatic stress disorder; Vagus nerve stimulation

Mesh:

Substances:

Year:  2018        PMID: 30091004      PMCID: PMC6368475          DOI: 10.1007/s00213-018-4994-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  6 in total

1.  Peripheral effects of vagus nerve stimulation on anxiety and extinction of conditioned fear in rats.

Authors:  Lindsey J Noble; Ashleigh Chuah; Kathleen K Callahan; Rimenez R Souza; Christa K McIntyre
Journal:  Learn Mem       Date:  2019-06-17       Impact factor: 2.460

2.  Transcutaneous Cervical Vagal Nerve Stimulation in Patients with Posttraumatic Stress Disorder (PTSD): A Pilot Study of Effects on PTSD Symptoms and Interleukin-6 Response to Stress.

Authors:  J Douglas Bremner; Matthew T Wittbrodt; Nil Z Gurel; MdMobashir H Shandhi; Asim H Gazi; Yunshen Jiao; Oleksiy M Levantsevych; Minxuan Huang; Joy Beckwith; Isaias Herring; Nancy Murrah; Emily G Driggers; Yi-An Ko; MhmtJamil L Alkhalaf; Majd Soudan; Lucy Shallenberger; Allison N Hankus; Jonathon A Nye; Jeanie Park; Anna Woodbury; Puja K Mehta; Mark H Rapaport; Viola Vaccarino; Amit J Shah; Bradley D Pearce; Omer T Inan
Journal:  J Affect Disord Rep       Date:  2021-07-10

3.  Sotalol Treatment may Interfere With Retrieval, Expression, and/or Reconsolidation Processes Thus Disrupting Traumatic Memories in a Post-Traumatic Stress Disorder Mice Model.

Authors:  Raquel Martinho; Rafaela Seixas; Márcia Azevedo; Ana Oliveira; Paula Serrão; Mónica Moreira-Rodrigues
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

4.  Timing of vagus nerve stimulation during fear extinction determines efficacy in a rat model of PTSD.

Authors:  Rimenez R Souza; Mark B Powers; Robert L Rennaker; Christa K McIntyre; Seth A Hays; Michael P Kilgard
Journal:  Sci Rep       Date:  2022-10-03       Impact factor: 4.996

5.  Editorial: the psychopharmacology of extinction-from theory to therapy.

Authors:  Amy L Milton; Andrew Holmes
Journal:  Psychopharmacology (Berl)       Date:  2019-01       Impact factor: 4.530

6.  Transcutaneous vagal nerve stimulation blocks stress-induced activation of Interleukin-6 and interferon-γ in posttraumatic stress disorder: A double-blind, randomized, sham-controlled trial.

Authors:  J Douglas Bremner; Nil Z Gurel; Yunshen Jiao; Matthew T Wittbrodt; Oleksiy M Levantsevych; Minxuan Huang; Hewon Jung; MdMobashir H Shandhi; Joy Beckwith; Isaias Herring; Mark H Rapaport; Nancy Murrah; Emily Driggers; Yi-An Ko; MhmtJamil L Alkhalaf; Majd Soudan; Jiawei Song; Benson S Ku; Lucy Shallenberger; Allison N Hankus; Jonathon A Nye; Jeanie Park; Viola Vaccarino; Amit J Shah; Omer T Inan; Bradley D Pearce
Journal:  Brain Behav Immun Health       Date:  2020-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.